United Therapeutics Corporation (UTHR) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About United Therapeutics Corporation
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and…
Source: Yahoo Finance
Sector & Industry
United Therapeutics Corporation operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
United Therapeutics Corporation at a Glance
| Company | United Therapeutics Corporation |
| Ticker | UTHR |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $487.61 |
| Market cap | $20.91B |
| P/E ratio (trailing) | 17.48 |
| EPS (trailing) | $27.89 |
| 52-week high | $609.35 |
| 52-week low | $388.73 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.56 |
| Return on equity (ROE) | 19.31% |
| Debt-to-equity | — |
| Average volume | 514,146 |
| Shares outstanding | 42.89M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 1,400 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is United Therapeutics Corporation's current P/E ratio?
- United Therapeutics Corporation (UTHR) has a trailing P/E ratio of 17.48 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is United Therapeutics Corporation's market capitalisation?
- United Therapeutics Corporation's market cap is $20.91B based on our latest snapshot. See how it ranks by market cap →
- What is UTHR's 52-week range?
- Over the past 52 weeks, UTHR has traded between $388.73 and $609.35. What does the 52-week range mean? →
- How volatile is United Therapeutics Corporation compared to the market?
- United Therapeutics Corporation has a beta of 0.56, meaning it has historically moved less than the broader market. What does beta measure? →
- Does United Therapeutics Corporation pay a dividend?
- United Therapeutics Corporation does not currently pay a dividend according to our latest data.
- What exchange is UTHR listed on?
- UTHR is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is United Therapeutics Corporation in?
- United Therapeutics Corporation is classified in the Healthcare sector. Compare with Healthcare peers →
Working out potential returns or position sizes? Our payout and odds calculators handle the maths.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →